Ling-Bo Qian

1.7k citations
55 papers · 1.4k indexed · h-index 22
Topics
Cardiac Ischemia and Reperfusion (14 papers)Cardiovascular Function and Risk Factors (10 papers)Nitric Oxide and Endothelin Effects (7 papers)

In The Last Decade

Ling-Bo Qian

50 papers receiving 1.4k citations

Peers

Ling-Bo Qian
Comparison fields: 5 of 96
  • Molecular Biology 559
  • Cardiology and Cardiovascular Medicine 249
  • Pathology and Forensic Medicine 222
  • Physiology 173
  • Endocrinology, Diabetes and Metabolism 145
Replace Xue Han with:
Xue Han China
Qiang Xia China
Huali Xu China
Joël de Leiris France
David M. Ansley Canada
Nilüfer Erkasap Türkiye
Dalaal M. Abdallah Egypt
Sharon Williams‐Ignarro Italy
Chunhua Zhu China
Ling-Bo Qian relative to Xue Han China Xue Han's profile →
Citations per field
00.5×1.7×
Xue Han · 1×
Citations per year

Countries citing papers authored by Ling-Bo Qian

Since Specialization
Citations

This map shows the geographic impact of Ling-Bo Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Bo Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Bo Qian more than expected).

Fields of papers citing papers by Ling-Bo Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling-Bo Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Bo Qian. The network helps show where Ling-Bo Qian may publish in the future.

Co-authorship network of co-authors of Ling-Bo Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Ling-Bo Qian. A scholar is included among the top collaborators of Ling-Bo Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling-Bo Qian. Ling-Bo Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 1
5 48
6 25
7 0
8 14
9 9
10 13
11 39
12 17
13 151
14 32
15 3
16 75
17 25
18 41
19 21
20 5

About Ling-Bo Qian

Ling-Bo Qian is a scholar working on Clinical Biochemistry, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (14 papers), Cardiovascular Function and Risk Factors (10 papers) and Nitric Oxide and Endothelin Effects (7 papers). The work is most often cited by research in Developmental Neuroscience (130 citations), Biochemistry (133 citations) and Complementary and alternative medicine (114 citations). Ling-Bo Qian has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qiang Xia, Chi Xiao, Iain C. Bruce, Xinru Zhou, Huiping Wang, Fengjiang Zhang, Lihui Tang, Leilei Ma, Zheng Xu and Min Yan. Their work appears in journals such as Brain Research, International Journal of Molecular Sciences and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026